ADRB1 and myocardial infarction: Some preliminary studies by Manivannan et al., 2015 and Mo et al., 2020 [41,42] have reported the potential cardioprotective responses of diosmetin, but there is no detailed study available related to the diosmetin effect on beta 1-adrenergic receptors, cardiac biomarkers, ECG pattern, myocardial infarction size and histopathology.